Get started
Author

Federica Giammarino

Observed names: F Giammarino, Giammarino, Federica
ORCID: 0000-0001-6775-3574
Observed ORCID: 0000-0001-6775-3574
OpenAlex ID: A5022661982
Evaluation of sofosbuvir activity and resistance profile against West Nile virus in vitro
2020 · Filippo Dragoni, Adele Boccuto, et al. · Antiviral Research · 51
Development of a Cell-Based Immunodetection Assay for Simultaneous Screening of Antiviral Compounds Inhibiting Zika and Dengue Virus Replication
2020 · Ilaria Vicenti, Filippo Dragoni, et al. · SLAS DISCOVERY · 23
PDF
In vitro cross-resistance to doravirine in a panel of HIV-1 clones harbouring multiple NNRTI resistance mutations
2020 · Francesco Saladini, Federica Giammarino, et al. · Journal of Antimicrobial Chemotherapy · 22
Efficacy of Licensed Monoclonal Antibodies and Antiviral Agents against the SARS-CoV-2 Omicron Sublineages BA.1 and BA.2
2022 · Lia Fiaschi, Filippo Dragoni, et al. · Viruses · 21
PDF
In vitro susceptibility to fostemsavir is not affected by long-term exposure to antiviral therapy in MDR HIV-1-infected patients
2020 · Francesco Saladini, Alessia Giannini, et al. · Journal of Antimicrobial Chemotherapy · 16
Switching the three-component Biginelli-like reaction conditions for the regioselective synthesis of new 2-amino[1,2,4]triazolo[1,5- a ]pyrimidines
2023 · Martina Pacetti, Maria Chiara Pismataro, et al. · Organic & Biomolecular Chemistry · 12
PDF
Privileged Scaffold Decoration for the Identification of the First Trisubstituted Triazine with Anti-SARS-CoV-2 Activity
2022 · Silvia Cesarini, Ilaria Vicenti, et al. · Molecules · 12
PDF
Optimization of potent, broad-spectrum, and specific anti-influenza compounds targeting RNA polymerase PA-PB1 heterodimerization
2024 · Anna Bonomini, Tommaso Felicetti, et al. · European Journal of Medicinal Chemistry · 10
In Vitro Combinatorial Activity of Direct Acting Antivirals and Monoclonal Antibodies against the Ancestral B.1 and BQ.1.1 SARS-CoV-2 Viral Variants
2024 · Lia Fiaschi, Camilla Biba, et al. · Viruses · 8
PDF
Combined doravirine and islatravir cooperate to inhibit NRTI and NNRTI resistant HIV-1 in vitro
2025 · Federica Giammarino, Chiara Paletti, et al. · Antiviral Research · 7
Residual phenotypic susceptibility to doravirine in multidrug-resistant HIV-1 from subjects enrolled in the PRESTIGIO Registry
2023 · Francesco Saladini, Federica Giammarino, et al. · International Journal of Antimicrobial Agents · 7
PDF
Decreased neutralization of the Eta SARS-CoV-2 variant by sera of previously infected and uninfected vaccinated individuals
2021 · Adele Boccuto, Filippo Dragoni, et al. · Journal of Infection · 6
PDF
Sofosbuvir Selects for Drug-Resistant Amino Acid Variants in the Zika Virus RNA-Dependent RNA-Polymerase Complex In Vitro
2021 · Adele Boccuto, Filippo Dragoni, et al. · International Journal of Molecular Sciences · 6
PDF
Single-shot design of a cyclic peptide inhibitor of HIV membrane fusion
2025 · Diandra Daumiller, Federica Giammarino, et al. · Antiviral Research · 5
HIV-1 Integrase Inhibition Activity by Spiroketals Derived from Plagius flosculosus, an Endemic Plant of Sardinia (Italy) and Corsica (France)
2023 · Cinzia Sanna, Brigida D’Abrosca, et al. · Pharmaceuticals · 5
Dynamics of Total and Intact HIV-1 DNA in Virologically Suppressed Patients Switching to DTG-Based or ATV-Based Dual Therapy
2022 · Filippo Dragoni, Barbara Rossetti, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 5
Serendipitous Identification of Azine Anticancer Agents Using a Privileged Scaffold Morphing Strategy
2024 · Silvia Cesarini, Ilaria Vicenti, et al. · Molecules · 4
PDF
Nucleoside Derivatives of 2,6‐Diaminopurine Antivirals: Base‐Modified Nucleosides with Broad‐Spectrum Antimicrobial Properties
2023 · Maria Grazia Martina, Federica Giammarino, et al. · ChemMedChem · 4
PDF
Broad synergistic antiviral efficacy between a novel elite controller-derived dipeptide and antiretrovirals against drug-resistant HIV-1
2024 · Federica Giammarino, Anders Sönnerborg, et al. · Frontiers in Cellular and Infection Microbiology · 3
Long-Term Longitudinal Analysis of Neutralizing Antibody Response to Three Vaccine Doses in a Real-Life Setting of Previously SARS-CoV-2 Infected Healthcare Workers: A Model for Predicting Response to Further Vaccine Doses
2022 · Saverio Giuseppe Parisi, Carlo Mengoli, et al. · Vaccines · 3
PDF
In vitro susceptibility of HIV-1 CRF02_AG to temsavir, the active compound of the attachment inhibitor fostemsavir
2021 · Francesco Saladini, Alessia Giannini, et al. · Journal of Antimicrobial Chemotherapy · 2
HIV-1 Sub-subtype A6 Remains Susceptible to Second-Generation Integrase Inhibitors With Limited Emergence of Resistance in Vitro
2026 · Francesco Saladini, Alessia Giannini, et al. · Open Forum Infectious Diseases · 1
Harnessing prebiotic formamide chemistry: a novel platform for antiviral exploration
2025 · Maria Grazia Martina, Chiara Vagaggini, et al. · Scientific Reports · 1
PDF
Regaining virological suppression in a woman living with a six‐class resistant HIV by combining injectable antiretroviral drugs guided by genotypic and phenotypic tests
2024 · Bianca Monti, Alessandro Soria, et al. · Journal of Medical Virology · 1
Prevalence and Phenotypic Susceptibility to Doravirine of the HIV-1 Reverse Transcriptase V106I Polymorphism in B and Non-B Subtypes
2024 · Federica Giammarino, Adolfo de Salazar, et al. · The Journal of Infectious Diseases · 1
PDF
Works count: 34
Citation count: 236
H-index: 8
I10-index: 8
Year
Topic
Type